Open AccessHairy cell leukemia
Author(s) -
Latif Salam,
Omar AbdelWahab
Publication year - 2015
Publication title -
current opinion in hematology/current opinion in hematology, with evaluated medline
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 1.295
H-Index - 97
eISSN - 1080-8213
pISSN - 1065-6251
DOI - 10.1097/moh.0000000000000154
Subject(s) - cladribine , purine analogue , pentostatin , medicine , hairy cell leukemia , vemurafenib , refractory (planetary science) , clinical trial , nucleoside analogue , oncology , leukemia , immunology , pharmacology , rituximab , purine , lymphoma , cancer , nucleoside , biology , biochemistry , metastatic melanoma , astrobiology , enzyme
In this review, we discuss the pathogenesis and standard therapeutic approach to hairy cell leukaemia (HCL) as well as newer targeted therapies under investigation showing promising end-points in treating HCL.